Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.128ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.128NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.451ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.451ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.451ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.451NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.313ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.313ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.313ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.313NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.402ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.402ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.402ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.402NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
B.1.609ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.609ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.609ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.609NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.344ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.344ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.344ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.344NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.556ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.556ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.556ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.556NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.245ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.245ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.245ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.245NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.403ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.403ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.403ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.403NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.636ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.636ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.636ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.636NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.126ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.126ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.126ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.126NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.47ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.47ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.47ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.47NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used